AI-generated summary
The authors studied six low-energy treatments with a fractionated 2940-nm Er:YAG laser in 16 people with photoaged skin, with 12 completing the trial. The authors report that all 12 completers recorded improvement and that no adverse events were reported, and they describe the procedure as safe and well tolerated.
- Participants
- 16
- Who or what was studied
- Sixteen subjects with photoaged skin (12 completed the trial)
- Wavelengths
- 2940 nm
- Limits stated in the abstract
- The abstract describes a small sample with no control group and relies on subject-reported outcomes and satisfaction.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Wavelength, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.